Effect of different pre-irradiation times on curcumin-mediated photodynamic therapy against planktonic cultures and biofilms of Candida spp

Archives of Oral Biology

Volumn 58, Issue 2, 2013, Pages 200-210

  Andrade, Mariana Carvalho ^a   Ribeiro, Ana Paula Dias ^b   Dovigo, Lívia Nordi ^a   Brunetti, Iguatemy Lourenço ^a   Giampaolo, Eunice Teresinha ^a   Bagnato, Vanderlei Salvador ^c   Pavarina, Ana Cláudia ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b UNIVERSITY OF BRASILIA   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Biofilms; Candida; Curcumin; Drug resistance; Photochemotherapy

Indexed keywords

CANDIDA; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; CANDIDA GLABRATA;

CURCUMIN; SUSPENSION;

BIOFILM; CANDIDA; CONFOCAL MICROSCOPY; CULTURE TECHNIQUE; DRUG EFFECTS; HUMAN; IN VITRO STUDY; PHOTOCHEMOTHERAPY; PROCEDURES; SUSPENSION; TIME;

BIOFILMS; CANDIDA; CELL CULTURE TECHNIQUES; CURCUMIN; HUMANS; IN VITRO TECHNIQUES; MICROSCOPY, CONFOCAL; PHOTOCHEMOTHERAPY; SUSPENSIONS; TIME FACTORS;

EID: 84874116756     PISSN: 00039969     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.archoralbio.2012.10.011     Document Type: Article

References (55)

1. Hoepelman IM, Dupont B. Oral Candidiasis: the clinical challenge of resistance and management. International Journal of Antimicrobial Agents 1996;6:155-9.
2. Kaur R, Domergue R, Zupancic ML, Cormack BP. A yeast by any other name: Candida glabrata and its interaction with the host. Current Opinion in Microbiology 2005;8: 378-84.
3. Sullivan DJ, Moran GP, Pinjon E, Al-Mosaid A, Stokes C, Vaughan C, et al. Comparison of the epidemiology, drug resistance mechanisms, and virulence of Candida dubliniensis and Candida albicans. FEMS Yeast Research 2004;4:369-76.
4. Akpan A, Morgan R. Oral candidiasis. Postgraduate Medical Journal 2002;78(922):455-9.
5. Abelson JA, Moore T, Bruckner D, Deville J, Nielsen K. Frequency of fungemia in hospitalized pediatric inpatients over 11 years at a tertiary care institution. Pediatrics 2005;116:61-7.
6. Perezous LF, Flaitz CM, Goldschmidt ME, Engelmeier RL. Colonization of Candida species in denture wearers with emphasis on HIV infection: a literature review. Journal of Prosthetic Dentistry 2005;93:288-93.
7. Cartledge JD, Midgley J, Gazzard BG. Non-albicans oral candidosis in HIV positive patients. Journal of Antimicrobial Chemotherapy 1999;43:419-22.
8. Hunter KD, Gibson J, Lockhart P, Pithie A, Bagg J. Fluconazole-resistant Candida species in the oral flora of fluconazole-exposed HIV-positive patients. Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontics 1998;85:558-64.
9. White TC, Marr KA, Bowden RA. Clinical, cellular and molecular factors that contribute to antifungal drug resistance. Clinical Microbiology Reviews 1998;11:382-402.
10. Sullivan DJ, Westerneng TJ, Haynes KA, Bennett DE, Coleman DC. Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals. Microbiology 1995;141:1507-21.
11. Sullivan D, Coleman D. Candida dubliniensis: characteristics and identification. Journal of Clinical Microbiology 1998;36: 329-34.
12. Chandra J, Mukherjee PK, Leidich SD, Faddoul FF, Hoyer LL, Douglas LJ, et al. Antifungal resistance of candidal biofilms formed on denture acrylic in vitro. Journal of Dental Research 2001;80:903-8.
13. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science 1999;284:1318-22.
14. Glass RT, Bullard JW, Hadley CS, Mix EW, Conrad RS. Partial spectrum of microorganisms found in dentures and possible disease implications. Journal of the American Osteopathic Association 2001;101:92-4.
15. Ribeiro DG, Pavarina AC, Dovigo LN, Palomari Spolidorio DM, Giampaolo ET, Vergani CE. Denture disinfection by microwave irradiation: a randomized clinical study. Journal of Dentistry 2009;37(9):666-72.
16. Wilson J. The aetiology, diagnosis and management of denture stomatitis. British Dental Journal 1998;185:380-4.
17. Martinez M, López-Ribot JL, Kirkpatrick WR, Coco BJ, Bachmann SP, Patterson TF. Replacement of Candida albicans with Candida dubliniensis in human immunodeficiency virusinfected patients with oropharyngeal candidiasis treated with fluconazole. Journal of Clinical Microbiology 2002;40:3135-9.
18. Calderone RA, Fonzi WA. Virulence factors of Candida albicans. Trends in Microbiology 2001;9:327-35.
19. Chandra J, Kuhn DM, Mukherjee PK, Hoyer LL, McCormick T, Ghannoum MA. Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. Journal of Bacteriology 2001;183:5385-94.
20. Douglas LJ. Candida biofilms and their role in infection. Trends in Microbiology 2003;11:30-6.
21. Budtz-Jorgensen E, Holmstrup P, Krogh P. Fluconazole in the treatment of Candida-associated denture stomatitis. Antimicrobial Agents and Chemotherapy 1988;32:1859-63.
22. Andes D, Forrest A, Lepack A, Nett J, Marchillo K, Lincoln L. Impact of antimicrobial dosing regimen on evolution of drug resistance in vivo: fluconazole and Candida albicans. Antimicrobial Agents and Chemotherapy 2006;50:2374-83.
23. Jabra-Rizk MA, Falkler WA, Meiller TF. Fungal biofilms and drug resistance. Emerging Infectious Diseases 2004;10:14-9.
24. Kirkpatrick WR, Revankar SG, Mcatee RK, Lopez-Ribot JL, Fothergill AW, McCarthy DI, et al. Detection of Candida dubliniensis in oropharyngeal samples from human immunodeficiency virus-infected patients in North America by primary CHROMagar Candida screening and susceptibility testing of isolates. Journal of Clinical Microbiology 1998;36:3007-12.
25. Chunchanur SK, Nadgir SD, Halesh LH, Patil BS, Kausar Y, Chandrasekhar MR. Detection and antifungal susceptibility testing of oral Candida dubliniensis from human immunodeficiency virus-infected patients. Indian Journal of Pathology and Microbiology 2009;52:501-4.
26. Jackson Z, Meghji S, MacRobert A, Henderson B, Wilson M. Killing of the yeast and hyphal forms of Candida albicans using a light-activated antimicrobial agent. Lasers in Medical Science 1999;14:150-7.
27. Jori G, Fabris C, Soncin M, Ferro S, Coppellotti O, Dei D, et al. Photodynamic therapy in the treatment of microbial infections: basic principles and perspective applications. Lasers in Surgery and Medicine 2006;38:468-81.
28. Machado AEH. Terapia fotodinâmica: princípios, potencial de aplicação e perspectivas. Química Nova 2000;32:237-43.
29. O'Riordan K, Akilov OE, Tayyaba H. The potential for photodynamic therapy in the treatment of localized infections. Photodiagnosis and Photodynamic Therapy 2005;2:247-62.
30. Wainwright M. Photodynamic antimicrobial chemotherapy (PACT). Journal of Antimicrobial Chemotherapy 1998;42:13-28.
31. Colussi VC, Nicola EMD, Nicola JH. Fototerapia, fotoquimioterapia e alguns fotossensibilizadores. Revista da Associacao Medica Brasileira 1996;42:229-36.
32. Bocking T, Barrow KD, Netting AG, Chilcott TC, Coster HGL, Hofer M. Effects of singlet oxygen on membrane sterols in the yeast Saccharomyces cerevisiae. European Journal of Biochemistry 2000;267:1607-18.
33. Lambrechts SAG, Aalders MCG, Van Marle J. Mechanistic study of the photodynamic inactivation of Candida albicans by cationic porphyrin. Antimicrobial Agents and Chemotherapy 2005;49:2026-34.
34. Chabrier-Rosello Y, Foster TH, Perez-Nazario N, Mitra S, Haidaris CG. Sensitivity of Candida albicans germ tubes and biofilms to photofrinmediated phototoxicity. Antimicrobial Agents and Chemotherapy 2005;49:4288-95.
35. Gomes ER, Cruz T, Lopes CF, Carvalho AP, Duarte CB. Photosensitization of lymphoblastoid cells with phthalocyanines at different saturating incubation times. Cell Biology and Toxicology 1999;15:249-60.
36. Dahl TA, McGowan WM, Shand MA, Srinivasan VS. Photokilling of bacteria by natural dye curcumin. Archives of Microbiology 1989;151:183-5.
37. Dahl TA, Belski P, Rezka KJ, Chignell CF. Photocytotoxicity of curcumin. Photochemistry and Photobiology 1994;59:290-4.
38. Demidova TN, Hamblin MR. Effect of cell-photosensitizer binding and cell density on microbial photoinactivation. Antimicrobial Agents and Chemotherapy 2005;49:2329-35.
39. Donnelly RF, McCarron PA, Tunney MM. Antifungal photodynamic therapy. Microbiological Research 2008; 163:1-12.
40. Dovigo LN, Pavarina AC, Mima EGO, Giampaolo ET, Vergani CE, Bagnato VS. Fungicidal effect of photodynamic therapy against fluconazole-resistant Candida albicans and Candida glabrata. Mycoses 2011;54:123-30.
41. Dovigo LN, Pavarina AC, Ribeiro APD, Brunetti IL, Costa CAS, Jacomassi DP, et al. Investigation of the photodynamic effects of curcumin against Candida albicans. Photochemistry and Photobiology 2011;87(4):895-903.
42. Pereira CA, Romeiro RL, Costa AC, Machado AK, Junqueira JC, Jorge AO. Susceptibility of Candida albicans, Staphylococcus aureus, and Streptococcus mutans biofilms to photodynamic inactivation: an in vitro study. Lasers in Medical Science 2011;26:341-8.
43. Tonnesen HH, Vries H, Karlsen J, Van Henegouwen GB. Studies on curcumin and curcuminoids IX: investigation of photobiological activity of curcumin using bacterial indicator systems. Journal of Pharmaceutical Sciences 1987;76:371-3.
44. Wood S, Nattress B, Kirkham J, Shore R, Brookes S, Griffiths J, et al. An in vitro study of the use of photodynamic therapy for the treatment of natural oral plaque biofilms formed in vivo. Journal of Photochemistry and Photobiology B 1999; 50:1-7.
45. Priyadarsini KI. Photophysics, photochemistry and photobiology of curcumin: studies from organic solutions, bio-mimetics and living cells. Journal of Photochemistry and Photobiology C Photochemistry Reviews 2009;10:81-95.
46. Sharma RA, Gescher AJ, Steward WP. Curcumin: the story so far. European Journal of Cancer 2005;41:1955-68.
47. Koon HK, Leung AWN, Yue KKM, Mak NK. Photodynamic effect of curcumin on NPC/CNE2 cells. Journal of Environmental Pathology Toxicology and Oncology 2006;25:205-15.
48. Silva WJ, Seneviratne J, Parahitiyawa N, Rosa EA, Samaranayake LP, Del Bel Cury AA. Improvement of XTT assay performance for studies involving Candida albicans biofilms. Brazilian Dental Journal 2008;19:364-9.
49. Seneviratne CJ, Silva WJ, Jin LJ, Samaranayake YH, Samaranayake LP. Architectural analysis, viability assessment and growth kinetics of Candida albicans and Candida glabrata biofilms. Archives of Oral Biology 2009;54(11):1052-60.
50. Bong PH. Spectral and photophysical behaviors of curcumin and curcuminoids. Bulletin of the Korean Chemical Society 2000;21:81-6.
51. Zeina B, Greenman J, Purcell WM, Das B. Killing of cutaneous microbial species by photodynamic therapy. British Journal of Dermatology 2001;144:274-8.
52. Ramage G, Walle KV, Wickes BL, López-Ribot JL. Biofilm formation by Candida dubliniensis. Journal of Clinical Microbiology 2001;39:3234-40.
53. Silva S, Henriques M, Oliveira R, Williams D, Azeredo J. In vitro biofilm activity of non-Candida albicans Candida species. Current Microbiology 2010;61:534-40.
54. Luo G, Samaranayake LP. Candida glabrata, an emerging fungal pathogen, exhibits superior relative cell surface hydrophobicity and adhesion to denture acrylic surfaces compared with Candida albicans. APMIS 2002;110:601-10.
55. Costa AC, de Campos Rasteiro VM, Pereira CA, da Silva Hashimoto ES, Beltrame Jr M, Junqueira JC, et al. Susceptibility of Candida albicans and Candida dubliniensis to erythrosine- and LED-mediated photodynamic therapy. Archives of Oral Biology 2011;56:1299-305.